SWS Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-180
Closed -$26.4K 205
2024
Q2
$26.4K Buy
+180
New +$26.8K 0.01% 190
2022
Q2
Sell
-119
Closed -$21K 97
2022
Q1
$21K Buy
+119
New +$20.2K 0.01% 96
2018
Q4
$1.5M Sell
11,583
-4,225
-27% -$589K 1.13% 39
2018
Q3
$2.68M Buy
15,808
+1,045
+7% +$139K 1.7% 15
2018
Q2
$1.79M Buy
14,763
+2,979
+25% +$372K 1.26% 38
2018
Q1
$1.47M Buy
11,784
+263
+2% +$35.5K 1.08% 42
2017
Q4
$1.61M Buy
+11,521
New +$1.6M 1.21% 34

Other funds holding JNJ

SWS Partners's JNJ Position: Q3 2024 in Review

SWS Partners sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 180 shares — an estimated $26.4K sold.

SWS Partners first reported a position in JNJ in Q4 2017 and held it in 7 quarters. The position peaked at $2.68M in Q3 2018. 3,882 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • SWS Partners reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • SWS Partners sold 180 Johnson & Johnson shares in Q3 2024, an estimated $26.4K.
  • SWS Partners first reported a position in Johnson & Johnson in Q4 2017 and held it in 7 quarters.
  • SWS Partners's Johnson & Johnson position peaked at $2.68M in Q3 2018.
  • 3,882 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on SWS Partners's 13F filing for Q3 2024, filed 15 Oct 2024.